Carl Öberg MD PhD
carloberg.bsky.social
Carl Öberg MD PhD
@carloberg.bsky.social
Associate Professor | PI Dialysis & Renal Physiology Group | Lund University Sweden 🇸🇪
Additional studies with indinavir (GLUT4-blocker) had no effect on FDG diffusion, leading us to conclude that the observed effects were likely the result of GLUT1-inhibition.
February 3, 2025 at 10:58 AM
In our study, we not only found that phloretin reduced FDG transfer, supporting our hypothesis of transcellular transfer, but also a significant reduction using GLUT1:GLUT4-blocker ritonavir.
February 3, 2025 at 10:58 AM
We hypothesized that the observed reduction in glucose absorption due to pan-GLUT-blocker phloretin was either due to a reduction in 1. trans-cellular glucose transfer and little trapping 2. cellular absorption and trapping in peritoneal cells, 3. para-cellular glucose transfer.
February 3, 2025 at 10:58 AM
Here, we tracked the journey of glucose across the peritoneal membrane studying both conventional glucose and radiolabeled glucose (18-F-deoxyglucose) in the opposite direction (plasma→dialysate). Diffusive transport capacities for glucose were similar regardless of the direction of transport.
February 3, 2025 at 10:58 AM